The decreased Fas level might down-regulate of Fas-induced apoptosis, while the elevated FASL level would enhance the ability of cancer cells to fight against immune system by killing FAS sensitive lymphocytes, which might subsequently affect chemotherapeutic response and change the prognosis of patients accepted chemotherapy 19,20. Here, FAS is linked to cancer.